Dexcom is using the soon-to-be released Apple Watch for its wearable glucose monitor. The Apple Watch showing a heartbeat. (Image courtesy of Apple) Nancy Crotti In the highly competitive, continuous-glucose-monitoring device ...
Tags: Apple Tech, Diabetes Tech
February 3, 2014 -- The U.S. Food and Drug Administration today approved the expanded use of the Dexcom G4 Platinum Continuous Monitoring System for patients with diabetes ages 2 to 17 years. The G4 Platinum System, which monitors blood ...
Tags: FDA
A Griffith University and Gold Coast Health program to help teenagers with diabetes better manage their condition has seen success on the Gold Coast. A joint collaboration between Griffith, Child, Youth and Mental Health Services, ...
Tags: diabetes, IPT, adolescent, Kelly Bowers
A so-called implantable insulin delivery device could one day free people with type 1 diabetes from the need for multiple daily injections, scientists say. "Diabetes is a difficult-to-treat condition, and yet keeping in very good balance ...
Animas Canada, a division of LifeScan Canada, has announced the launch of the Animas Vibe insulin pump and CGM system in Canada , providing a new diabetes management solution for Canadians living with Type 1 diabetes. Animas Vibe is an ...
Tags: CGM, Dexcom, Diabetes, Animas Vibe
Novo Nordisk, a world leader in diabetes care, today announced the launch of the insulin delivery device NovoPen Echo® in the United States. This is the first and only pen device available in the U.S. with half-unit dosing and a memory ...
Brian Otis gingerly holds what looks like a typical contact lens on his index finger. Look closer. Sandwiched in this lens are two twinkling glitter-specks loaded with tens of thousands of miniaturized transistors. It's ringed with a ...
Tags: Consumer Electronics, Electronics
The incidence of auto-immune diseases like type 1 diabetes and allergies has risen dramatically in developed countries over the past fifty years. The reasons for this trend are not fully understood but a theory known as the 'hygiene ...
Tags: auto-immune diseases, hygiene hypothesis, Diabimmune, hygiene standards
A vaccine normally used to thwart the respiratory illness tuberculosis also might help prevent the development of multiple sclerosis, a disease of the central nervous system, a new study suggests. In people who had a first episode of ...
People with type 2 diabetes might be at somewhat higher risk of developing liver cancer, according to a large, long-term study. The research suggests that those with type 2 diabetes have about two to three times greater risk of developing ...
Tags: type 2 diabetes, liver cancer, hepatocellular carcinoma
US-based biopharmaceutical company MannKind has resubmitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking marketing authorization for its AFREZZA inhalation powder, indicated to improve glycemic control ...
Tags: Insulin Application, biopharmaceutical company MannKind
Israel-based oral drug delivery systems developer Oramed Pharmaceuticals has received two additional patent approvals in Japan and Canada for its platform protein oral delivery (POD) technology. The two patents are entitled 'Methods and ...
Tags: Pod Technology, Oramed
The Russia's Federal Service for Intellectual Property, Patents and Trademarks has issued a patent to Israel-based Oramed Pharmaceuticals related to methods and compositions for oral administration of proteins. The patent titled "Methods ...
Israel-based oral drug delivery systems developer Oramed Pharmaceuticals has received an approval for a patent, titled 'Methods and Compositions for Oral Administrations of Proteins', from the State Intellectual Property Office of the ...
US-based Medtronic's sensor-augmented insulin pump with Threshold Suspend feature safely reduces nocturnal hypoglycemia without affecting glycated hemoglobin level (HbA1C), a study results show. Threshold Suspend, which is claimed to be ...
Tags: Health, Medicine, Hypoglycemia